Cervomed Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.95

+0.15 (+3.95%)

As of May 16, 2:20 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +813.4% upside

Low Target $23.71

Average Target $36.08

High Target $52.26

Current Price $3.95

Current
$3.95

Target
$36.08

$23.71 $36.08 avg $52.26

Scenario Analysis

Bear Case

$23.71

500.3%

Low target

Base Case

$36.08

+813.4%

Avg target

Bull Case

$52.26

+1,223.0%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$13.13

-69.9% from high

52-Week Low

$3.51

+12.5% from low

Target vs 52W High

$36.08

+174.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%